Iwata T, Tamanaha T, Koezuka R, Tochiya M, Makino H, Kishimoto I, Mizusawa N, Ono S, Inoshita N, Yamada S, Shimatsu A, Yoshimoto K
Department of Medical PharmacologyInstitute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto-cho 3-18-15, Tokushima 770-8504, JapanDepartment of Endocrinology and MetabolismNational Cerebral and Cardiovascular Center, Osaka, JapanDepartments of PathologyHypothalamic and Pituitary SurgeryToranomon Hospital, Tokyo, JapanClinical Research InstituteNational Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Department of Medical PharmacologyInstitute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto-cho 3-18-15, Tokushima 770-8504, JapanDepartment of Endocrinology and MetabolismNational Cerebral and Cardiovascular Center, Osaka, JapanDepartments of PathologyHypothalamic and Pituitary SurgeryToranomon Hospital, Tokyo, JapanClinical Research InstituteNational Hospital Organization Kyoto Medical Center, Kyoto, Japan
Eur J Endocrinol. 2015 Jan;172(1):K5-10. doi: 10.1530/EJE-14-0685. Epub 2014 Oct 21.
The objective was to assess involvement of loss of the PRKAR1A gene encoding a type 1α regulatory subunit of cAMP-dependent protein kinase A located on 17q24 in a Carney complex (CNC)-related pituitary adenoma.
We investigated aberrations of the PRKAR1A gene in a CNC patient with a GH-producing pituitary adenoma, whose family has three other members with probable CNC.
A gene mutation was identified by a standard DNA sequencing method based on PCR. DNA copy number was measured to evaluate allelic loss on 17q24 by quantitative PCR. The breakpoints of deletion were determined by cloning a rearranged region in the deleted allele.
A PRKAR1A mutation of c.751_758del8 (p.S251LfsX16) was found in genomic DNA obtained from a pituitary adenoma, but not leukocytes from the patient. Reduced DNA copy number at loci including the PRKAR1A gene on 17q24 was detected in both the tumor and leukocytes, suggesting a deletion at the loci at the germline level. The deletion size was determined to be ∼ 0.5 Mb and this large deletion was also found in two other family members.
This is the first case showing a CNC-related pituitary adenoma with the combination of somatic mutation and a large inherited deletion of the PRKAR1A gene. Biallelic inactivation of PRKAR1A appears to be necessary for the development of CNC-related pituitary adenoma.
评估位于17q24的编码环磷酸腺苷依赖性蛋白激酶A 1α型调节亚基的PRKAR1A基因缺失在卡尼综合征(CNC)相关垂体腺瘤中的作用。
我们调查了一名患有生长激素分泌型垂体腺瘤的CNC患者的PRKAR1A基因畸变情况,其家族中还有其他三名可能患有CNC的成员。
通过基于聚合酶链反应(PCR)的标准DNA测序方法鉴定基因突变。通过定量PCR测量DNA拷贝数以评估17q24上的等位基因缺失。通过克隆缺失等位基因中的重排区域来确定缺失的断点。
在从垂体腺瘤获得的基因组DNA中发现了PRKAR1A基因的c.751_758del8(p.S251LfsX16)突变,但在患者的白细胞中未发现。在肿瘤和白细胞中均检测到17q24上包括PRKAR1A基因在内的位点的DNA拷贝数减少,表明在种系水平上这些位点存在缺失。确定缺失大小约为0.5 Mb,并且在另外两名家族成员中也发现了这种大的缺失。
这是首例显示出CNC相关垂体腺瘤伴有PRKAR1A基因体细胞突变和大的遗传性缺失的病例。PRKAR1A的双等位基因失活似乎是CNC相关垂体腺瘤发生所必需的。